Cara Therapeutics Inc (CARA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

4 STAMFORD PLAZA STAMFORD, CT 06902

Cara Therapeutics, Inc. develops therapeutics. The Company offers novel drugs for the treatment of human diseases associated with pain and inflammation. Cara Therapeutics serves customers in the United States.

Data as of 2020-09-12
Market Cap699.081 Million Shares Outstanding46.887 Million Avg 30-day Volume340.747 Thousand
P/E Ratio Dividend Yield EPS-2.51
Price/Sales29.101 Price cash flow ratio477.4 Price free cash flow ratio-5.8
Book Value3.01 Price to Tangible Book5.03 Alpha-0.0
Short Interest Ratio % Short Interest to Float R-squared0.132109
BETA1.70048 52-week High/Low26.67 / 8.88 Stddev0.199901
View SEC Filings from CARA instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 3 0.0% 1 (0.07%) 1 (0.06%) 0.0%
Funds Holding: 144 135 6.67% 34 (2.22%) 31 (1.98%) 9.68%
13F shares: 32.689 Million 32.202 Million 1.51% 12.186 Million 12.143 Million 0.35%
% Ownership 69.8552 68.9143 1.37% 26.0398 25.9865 0.21%
New Positions: 33 21 57.14% 11 7 57.14%
Increased Positions 46 36 27.78% 12 10 20.0%
Closed Positions 23 33 -30.3% 8 16 -50.0%
Reduced Positions 27 44 -38.64% 6 9 -33.33%
Total Calls 562.193 Thousand 477.993 Thousand 17.62% 88.7 Thousand 219.3 Thousand -59.55%
Total Puts 376.898 Thousand 307.472 Thousand 22.58% 33.9 Thousand 50.8 Thousand -33.27%
PUT/CALL Ratio 0.67 0.64 4.69% 0.38 0.23 65.22%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CARA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CARA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

8.2 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CHALMERS DEREK T PRESIDENT & CEO

  • Officer
  • Director
953,220 2020-09-03 12

SHIFF SUSAN PH.D.

  • Director
0 2020-06-26 2

GONCALVES JOANA CHIEF MEDICAL OFFICER

  • Officer
35,373 2020-06-10 2

BAINS HARRISON M JR

  • Director
13,200 2020-06-04 1

IVES JEFFREY L.

  • Director
13,200 2020-06-04 10

VOGELBAUM MARTIN

  • Director
20,400 2020-06-04 1

POSNER CHRISTOPHER

  • Director
13,200 2020-06-04 1

MENZAGHI FREDERIQUE PH.D. CHIEF SCIENTIFIC OFF,SVP-R&D

  • Officer
104,492 2020-04-17 6

TERRILLION SCOTT SEC'Y; CHIEF COMPLIANCE & G.C.

  • Officer
38,382 2020-04-17 3

MAKARA RICHARD VP, HEAD OF ACCTING;CONTROLLER

  • Officer
0 2020-02-24 2

MOHINDRU MANI CFO & CHIEF STRATEGY OFFICER

  • Officer
17,441 2019-12-02 1

STAUFFER JOSEPH WILLIAM CHIEF MEDICAL OFFICER

  • Officer
2,000 2018-10-17 0

SCHOELL JOSEF CHIEF FINANCIAL OFFICER

  • Officer
50,000 2017-07-26 0

SLAGEL DEAN

  • Director
1,064,338 2017-06-29 0

RHO VENTURES VI LP

RMV VI, L.L.C.

RHO CAPITAL PARTNERS LLC

LESCHLY MARK

KAIROUZ HABIB

RUCH JOSHUA

  • 10% Owner
3,568,057 2017-03-31 0

LEWIS MICHAEL E CHIEF SCIENTIFIC ADVISOR

  • Officer
0 2017-03-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CHALMERS DEREK T - Director - Officer PRESIDENT & CEO

2020-09-08 17:22:16 -0400 2020-09-03 S 3,201 $16.00 d 953,220 direct yes -3.141 -3.141 0.0 1 -4.4231 3

CHALMERS DEREK T - Director - Officer PRESIDENT & CEO

2020-08-05 18:20:45 -0400 2020-08-03 S 5,000 $16.42 d 956,421 direct yes -0.1767 -0.6478 -14.4287 2.6502 4 -14.4287 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments